BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sultan K, Mone A, Durbin L, Khuwaja S, Swaminath A. Review of inflammatory bowel disease and COVID-19. World J Gastroenterol 2020; 26(37): 5534-5542 [PMID: 33088153 DOI: 10.3748/wjg.v26.i37.5534]
URL: https://www.wjgnet.com/1007-9327/full/v26/i37/5534.htm
Number Citing Articles
1
Richard Taylor, Daniel Mallon. COVID-19 and Pediatric GastroenterologyPediatric Clinics of North America 2021; 68(6): 1157 doi: 10.1016/j.pcl.2021.07.003
2
Shao Liu, Mi-Mi Tang, Jie Du, Zhi-Cheng Gong, Shu-Sen Sun. COVID-19 in gastroenterology and hepatology: Lessons learned and questions to be answeredWorld Journal of Clinical Cases 2021; 9(17): 4199-4209 doi: 10.12998/wjcc.v9.i17.4199
3
Xiaomei Wang, Guoliang Zhou, Wanwan Zhou, Xin Wang, Xiao Wang, Chenggui Miao. Exosomes as a New Delivery Vehicle in Inflammatory Bowel DiseasePharmaceutics 2021; 13(10): 1644 doi: 10.3390/pharmaceutics13101644
4
Javier del Hoyo, Mónica Millán, Alejandro Garrido-Marín, Pilar Nos, Manuel Barreiro-de Acosta, Luis Bujanda, Fernando de la Portilla, Mariam Aguas. Changes in the management of IBD patients since the onset of COVID-19 pandemic. A path toward the implementation of telemedicine in Spain?Gastroenterología y Hepatología (English Edition) 2022; 45(9): 697 doi: 10.1016/j.gastre.2021.08.004
5
Daniele Napolitano, Linda Galasso, Giuseppe Privitera, Giuseppe Morana, Arianna Bardelli, Rita Sinatora, Maria Francesca Onidi, Maria Teresa Lombardi, Nicoletta Orgiana, Valeria Amatucci, Martina Strazzeri, Elisa Schiavoni, Laura Turchini, Alessandra Guarini, Carlo Romano Settanni, Alessandro Armuzzi, Franco Scaldaferri. The role of inflammatory bowel disease nurses for patients on biologic therapy during the COVID-19 pandemicGastrointestinal Nursing 2022; 20(2): 40 doi: 10.12968/gasn.2022.20.2.40
6
Isa Seida, Zeynep Betul Balcioglu, Kamyar Neyestani, Naim Mahroum. Infection and Autoimmunity2024; : 823 doi: 10.1016/B978-0-323-99130-8.00011-8
7
Kristian Marling Moum, Bjørn Moum, Randi Opheim. Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives’ on COVID-19 and health care service during the pandemicScandinavian Journal of Gastroenterology 2021; 56(5): 545 doi: 10.1080/00365521.2021.1901308
8
Siva Sundara Kumar Durairajan, Abhay Kumar Singh, Udhaya Bharathy Saravanan, Mayurikaa Namachivayam, Moorthi Radhakrishnan, Jian-Dong Huang, Rahul Dhodapkar, Hongjie Zhang. Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical ImplicationsViruses 2023; 15(6): 1231 doi: 10.3390/v15061231
9
Javier del Hoyo, Mónica Millán, Alejandro Garrido-Marín, Pilar Nos, Manuel Barreiro-de Acosta, Luis Bujanda, Fernando de la Portilla, Mariam Aguas. Changes in the management of IBD patients since the onset of COVID-19 pandemic. A path toward the implementation of telemedicine in Spain?Gastroenterología y Hepatología 2022; 45(9): 697 doi: 10.1016/j.gastrohep.2021.08.006
10
Simcha Weissman, Muhammad Aziz, Wade-Lee Smith, Sameh Elias, Arun Swaminath, Joseph D. Feuerstein. Safety of biologics in inflammatory bowel disease patients with COVID-19International Journal of Colorectal Disease 2021; 36(9): 2051 doi: 10.1007/s00384-021-03977-9
11
Katerina G Oikonomou, Panagiotis Papamichalis, Tilemachos Zafeiridis, Maria Xanthoudaki, Evangelia Papapostolou, Asimina Valsamaki, Konstantinos Bouliaris, Michail Papamichalis, Marios Karvouniaris, Panagiotis J Vlachostergios, Apostolia-Lemonia Skoura, Apostolos Komnos. Gastroenterology and liver disease during COVID-19 and in anticipation of post-COVID-19 era: Current practice and future directionsWorld Journal of Clinical Cases 2021; 9(19): 4918-4938 doi: 10.12998/wjcc.v9.i19.4918
12
Fei Chen, Zhiqing Dai, Chaofan Huang, Huiran Chen, Xinyi Wang, Xinya Li. Gastrointestinal Disease and COVID-19: A Review of Current EvidenceDigestive Diseases 2022; 40(4): 506 doi: 10.1159/000519412
13
Gian Mario Cortes, Maria Antonietta Marcialis, Flaminia Bardanzellu, Angelica Corrias, Vassilios Fanos, Michele Mussap. Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same CoinFrontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.856165
14
Viktoriya Sokolova, Jana‐Fabienne Ebel, Sebastian Kollenda, Kai Klein, Benedikt Kruse, Claudia Veltkamp, Christian M. Lange, Astrid M. Westendorf, Matthias Epple. Uptake of Functional Ultrasmall Gold Nanoparticles in 3D Gut Cell ModelsSmall 2022; 18(31) doi: 10.1002/smll.202201167
15
Naser-Aldin Lashgari, Nazanin Momeni Roudsari, Saeideh Momtaz, Amir Hossein Abdolghaffari. Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatmentWorld Journal of Gastroenterology 2021; 27(46): 7943-7955 doi: 10.3748/wjg.v27.i46.7943
16
Zijun Gu, Junyi Gu, Ping Liu. The effectiveness of continuity of care in patients with inflammatory bowel disease: a systematic reviewBMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-023-03109-3
17
Marouf Alhalabi, Kamal Alaa Eddin, Khaled Cheha, Ahmad Abbas. Subcutaneous golimumab induced and maintained clinical response in a child with a biological-experienced steroid-refractory flare of ulcerative colitisMedicine 2021; 100(38): e27283 doi: 10.1097/MD.0000000000027283
18
Benedetto Neri, Giorgia D’Agostini, Silvia Salvatori, Michelangela Mossa, Federica Bettin, Roberto Mancone, Irene Marafini, Elisabetta Lolli, Emma Calabrese, Giovanni Monteleone, Livia Biancone. Severe acute respiratory syndrome coronavirus 2 infection does not worsen the course of inflammatory bowel disease in the long termEuropean Journal of Gastroenterology & Hepatology 2023; 35(9): 948 doi: 10.1097/MEG.0000000000002554
19
Saeed Shakibfar, Jing Zhao, Huiqi Li, Hedvig Nordeng, Angela Lupattelli, Milena Pavlovic, Geir Kjetil Sandve, Fredrik Nyberg, Björn Wettermark, Mohammadhossein Hajiebrahimi, Morten Andersen, Maurizio Sessa. Machine learning-driven development of a disease risk score for COVID-19 hospitalization and mortality: a Swedish and Norwegian register-based studyFrontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.1258840
20
Elham Tabesh, Maryam Soheilipour, Mohammad Rezaeisadrabadi, Elahe Zare-Farashbandi, Razieh Sadat Mousavi-Roknabadi. Comparison the effects and side effects of Covid-19 vaccination in patients with inflammatory bowel disease (IBD): a systematic scoping reviewBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02460-1
21
Lu Lu, Le-Ping Liu, Rong Gui, Hang Dong, Yan-Rong Su, Xiong-Hui Zhou, Feng-Xia Liu. Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approachFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.975848
22
Karen C. Young, Vitaliy Poylin. Consequences of Delayed Endoscopies on the IBD Population during the COVID-19 PandemicWorld Journal of Colorectal Surgery 2022; 11(3): 55 doi: 10.4103/wjcs.wjcs_28_22
23
Ken Nagayasu, Sunao Fujiyoshi, Shigenori Honma, Nobuki Ichikawa, Tadashi Yoshida, Kengo Shibata, Hiroki Matsui, Takehiko Katsurada, Sho Nakakubo, Kanako Hatanaka, Akinobu Taketomi. A Case of Ulcerative Colitis That Worsened Due to Coronavirus Disease 2019 and Was Treated with Subtotal ColectomyThe Japanese Journal of Gastroenterological Surgery 2024; 57(4): 204 doi: 10.5833/jjgs.2023.0043
24
Enrik John T. Aguila, Ian Homer Y. Cua, Rajvinder Singh. Effects of coronavirus disease 2019 on the digestive system and its nutritional implicationsCurrent Opinion in Clinical Nutrition & Metabolic Care 2021; 24(5): 440 doi: 10.1097/MCO.0000000000000785
25
Satyaki Roy, Shehzad Z. Sheikh, Terrence S. Furey. A machine learning approach identifies 5-ASA and ulcerative colitis as being linked with higher COVID-19 mortality in patients with IBDScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-95919-2
26
Keisuke Naito, Tomoyo Narita, Yukari Murata, Naoto Morimura. Risk factors associated with hospital transfer among mild or asymptomatic COVID-19 patients in isolation facilities in Tokyo: a case-control studyIJID Regions 2022; 2: 8 doi: 10.1016/j.ijregi.2021.11.001